CVE Intelligence
Skip to main content

CVE-2015-1012

CVE-2015-1012 Vulnerability Analysis & Exploit Intelligence

Wireless keys are stored in plain text on version 5 of the Hospira LifeCare PCA Infusion System. According to Hospira, version 3 of the LifeCare PCA Infusion System is not indicated for wireless use, is not shipped with wireless capabilities, and should not be modified to be used in a wireless capacity in a clinical setting. Hospira has developed a new version of the PCS Infusion System, version 7.0 that addresses the identified vulnerabilities. Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.

Published Updated Sources: cvelistV5, icscert

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.

Exploitation

Unreported

no source claims exploitation

EPSS

1%

chance of exploitation in 30 days

Affects

hospira

lifecare_pca_infusion_system

CVSS base

Unscored

no source published a base score

Affected scope

The catalog records vendors and products as separate lists, not pairs, so which product belongs to which vendor is not something this page can say.

Vendors (1)

hospira

Products (1)

lifecare pca infusion system

Weakness & attack patterns

  • CWE-312

Attack patterns reported against this CVE. The ATT&CK techniques below are inferred from its weakness class.

  • T1005Data from Local System
  • T1552.004Unsecured Credentials: Private Keys

Detection

Read off the CVSS vector and the weakness class. Starting points, not rules we have tested.

  • Search application, proxy, and WAF logs for requests touching /FTP, /TELNET.

References

1 on the record

Elsewhere on this site

  • hospiraevery CVE for this vendor
  • CWE-312other pages naming this weakness

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.